KRAS Protein Variant
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma (NCT04106362) | Jonsson Comprehensive Cancer Center | 2020-01-14 |
Track KRAS Protein Variant automatically
Every clearance here is in the API, with alerts when new ones post.